MedTrace Logo

Dual Site Left Ventricular (LV) Pacing

NCT00944125 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-10-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare Dual LV (left ventricular) pacing to standard single LV pacing (BiV pacing) to see if Dual LV pacing:

1. Improves the way the heart's left ventricle functions
2. Decreases the number of hospital and clinic visits for heart failure related symptoms
3. Slows the rate patients experience certain heart failure symptoms
4. Reduces uncoordinated heart contractions

Conditions

  • Congestive Heart Failure
  • LV Dysfunction

Interventions

DEVICE

Dual Site LV Pacing

Dual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.

DEVICE

BiV Pacing

Dual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Imran K Niazi, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944125 on ClinicalTrials.gov